Previous Close | 11.61 |
1-Year Change | 52.76% |
6-Months Change | -26.15% |
3-Months Change | 31.48% |
Moving Avg (50d) | 11.243 |
Moving Avg (200d) | 10.573 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 325.6M |
Beta (3-Years) | 0.97 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | % |
Return On Assets (ttm) | -28.24% |
EPS (ttm) | -2.12 |
PE Ratio (ttm) | -5.48 |
Dividend Yield | % |
Asset Description: | Astria Therapeutics, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-08-13 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
11.378 | 11.029 | 10.797 | 10.449 | 9.868 | 9.288 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |